| Carboplatin/Paclitaxel Regimen studied in …STUDIED_INderived59 of 59show fewer |
|---|
| → studied in | NCT05061550Phase 2 · recruiting Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07836049Phase 2 · not yet recruiting PhII Study of Toripalimab Followed by Definitive CRT & Adjuvant Toripalimab in Locally Advanced ESCC · 59 trials list this drug (23 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831902Phase 3 · recruiting Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer · 59 trials list this drug (23 active) | — | — | Uterine Neoplasm,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07365319Phase 2/Phase 3 · recruiting A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer. · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776171Phase 2 · not yet recruiting Trastuzumab Rezetecan and Carboplatin ± Bevacizumab Versus Investigator's Choice Chemotherapy in Patients With Platinum-sensitive Recurrent Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm,Platinum-Sensitive Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02453282Phase 3 · active not recruiting Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC) · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02542293Phase 3 · active not recruiting Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE) · 59 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03519971Phase 3 · completed Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699757Phase 1 · not yet recruiting HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion · 59 trials list this drug (23 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03737643Phase 3 · active not recruiting Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03003962Phase 3 · active not recruiting Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL) · 59 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07632079Phase 2 · recruiting Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer · 59 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07610525Phase 2 · not yet recruiting Blood and imagE-guided Optimization of Neoadjuvant Therapy in People With Early Stage Triple-negative Breast cancER - the BETTER Trial · 59 trials list this drug (23 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05294900Phase 2 · completed Trial of Neoadjuvant Therapy With Paclitaxel and Carboplatin in Operable Locally Advanced Head and Neck Cancer Patients · 59 trials list this drug (23 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06102252NA · completed Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma · 59 trials list this drug (23 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07401654Phase 2 · not yet recruiting The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07171606Phase 2 · recruiting A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients · 59 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06353906Phase 2 · recruiting Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer · 59 trials list this drug (23 active) | — | — | Urinary Tract Neoplasm,Penile Squamous Cell Carcinoma,Malignant Penile Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05201547Phase 3 · active not recruiting Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line · 59 trials list this drug (23 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307785Phase 1 · completed Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042 · 59 trials list this drug (23 active) | — | — | Neoplasm,Malignant Neoplasm,Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07107217Phase 2 · not yet recruiting Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer · 59 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00516724Phase 1 · completed Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03168880Phase 3 · active not recruiting A Randomized Controlled Trial of Neoadjuvant Weekly Paclitaxel Versus Weekly Paclitaxel Plus Weekly Carboplatin In Women With Large Operable or Locally Advanced, Triple Negative Breast Cancer · 59 trials list this drug (23 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06715501NA · enrolling by invitation Efficacy and Safety of Cadonilimab and Chemoradiotherapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma · 59 trials list this drug (23 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460352Phase 3 · recruiting Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer · 59 trials list this drug (23 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06713057Phase 2 · not yet recruiting Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer · 59 trials list this drug (23 active) | — | — | Malignant Thyroid Gland Neoplasm,Thyroid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01969578Phase 2 · completed Androgen Deprivation Therapy in Advanced Salivary Gland Cancer · 59 trials list this drug (23 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04807166Phase 2 · active not recruiting Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Neoplasm,Neoplasm by Site,Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01506856Phase 2/Phase 3 · completed Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial · 59 trials list this drug (23 active) | — | — | Primary Peritoneal Carcinoma,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963334Phase 1/Phase 2 · completed Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01367002Phase 2 · completed Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer · 59 trials list this drug (23 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04030000Phase 1/Phase 2 · withdrawn Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation · 59 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05371301Phase 3 · unknown Efficacy of Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Stage IV Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04982549Phase 2 · unknown A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04137653Phase 3 · recruiting Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT · 59 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04337632Phase 3 · unknown Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00576225Phase 3 · withdrawn CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658214Phase 1 · completed Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors · 59 trials list this drug (23 active) | — | — | Carcinoma,Gastric Neoplasm,Peritoneal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00226915Phase 3 · completed Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma · 59 trials list this drug (23 active) | — | — | Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03940001early Phase 1 · unknown A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer · 59 trials list this drug (23 active) | — | — | Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03562533completed Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer · 59 trials list this drug (23 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02924909Phase 2 · unknown Phase II Trial of Neoadjuvant Treatment and Minimal Invasive Surgery for Esophageal and GEJ Cancer · 59 trials list this drug (23 active) | — | — | Malignant Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01160601Phase 2 · completed Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02207361Phase 4 · unknown Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer · 59 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00538603NA · completed Multi-national, Randomized, Phase III, GCIG Intergroup Study Comparing Pegylated Liposomal Doxorubicin (CAELYX) and Carboplatin vs. Paclitaxel and Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse. (CALYPSO) · 59 trials list this drug (23 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00873119Phase 2 · completed Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary · 59 trials list this drug (23 active) | — | — | Carcinoma of Unknown Primary | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254891Phase 3 · terminated Trial of Paclitaxel/Carboplatin + PF-3512676 vs Paclitaxel/Carboplatin Alone in Patients With Advanced Non-Small Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00111007Phase 3 · completed A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma · 59 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00919880Phase 2 · completed Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer · 59 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00298415Phase 3 · completed Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196234Phase 2 · completed Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00147680Phase 2 · completed Uterine Papillary Serous Cancer (UPSC) Trial · 59 trials list this drug (23 active) | — | — | Malignant Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00708812Phase 2 · completed Paclitaxel Plus Carboplatin With or Without Endostar in Patients With Advanced Non-small Cell Lung Cancer · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00340184Phase 2 · completed A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients · 59 trials list this drug (23 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01203267Phase 2 · completed Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer · 59 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01158144Phase 2 · unknown Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00894569Phase 2 · unknown Paclitaxel/Carboplatin With or Without Cetuximab in CUP · 59 trials list this drug (23 active) | — | — | Neoplasm,Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087802Phase 3 · completed Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00061646Phase 2 · terminated Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) · 59 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |